Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.04
Day High 0.05
Open:0.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Prometic announces terms of equity rights offering
- CNW Group - CND - Wed May 15, 2:08PM CDT
CNW Group - CND - CMTX
Wed May 15, 2:08PM CDT
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Prometic reports its 2019 first quarter financial results
- CNW Group - Wed May 8, 6:46PM CDT
CNW Group - CMTX
Wed May 8, 6:46PM CDT
Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") reported today its unaudited financial results for the first quarter ended March 31, 2019.
Prometic reports its 2019 first quarter financial results
PR Newswire - Wed May 8, 6:46PM CDT
PR Newswire - PRNW
Wed May 8, 6:46PM CDT
LAVAL, QC , May 8, 2019 /PRNewswire/ -  Prometic Life Sciences Inc.  (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") reported today its unaudited financial results for the first quarter ended March 31, 2019 .
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.04 +25.00% increase
on 05/22/19
Period Open:0.06
Price movement based on the high, low and last over the given period.
0.07 -28.57% decrease
on 04/29/19
-0.01 (-16.67%) decrease
since 04/26/19
3-Month 0.04 +25.00% increase
on 05/22/19
Period Open:0.40
Price movement based on the high, low and last over the given period.
0.41 -87.80% decrease
on 02/28/19
-0.35 (-87.50%) decrease
since 02/27/19
52-Week 0.04 +25.00% increase
on 05/22/19
Period Open:0.77
Price movement based on the high, low and last over the given period.
1.01 -95.05% decrease
on 07/11/18
-0.72 (-93.51%) decrease
since 05/25/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).